GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Current Deferred Revenue

Techno Drugs (DHA:TECHNODRUG) Current Deferred Revenue : BDT0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Techno Drugs Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Techno Drugs's current deferred revenue for the quarter that ended in Dec. 2024 was BDT0 Mil.

Techno Drugs Current Deferred Revenue Historical Data

The historical data trend for Techno Drugs's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Drugs Current Deferred Revenue Chart

Techno Drugs Annual Data
Trend
Current Deferred Revenue

Techno Drugs Quarterly Data
Sep23 Dec23 Sep24 Dec24
Current Deferred Revenue - - - -

Techno Drugs Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Techno Drugs's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Techno Drugs Business Description

Traded in Other Exchanges
N/A
Address
31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Techno Drugs Headlines

No Headlines